Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc. is advancing its Enhanced Delivery Oligonucleotide platform, which has demonstrated significant potential in enhancing the delivery of oligonucleotide therapeutics for severe neuromuscular and neurologic diseases. Recent preclinical studies indicate a substantial improvement in splicing correction, with a notable enhancement observed when excluding outlier data, which highlights the efficacy of its pipeline products. The company's strong focus on optimizing tissue penetration and delivery positions it favorably in the biotechnology market, with a best-case scenario estimating a significant stock performance increase should clinical results meet certain thresholds.

Bears say

PepGen Inc faces several risks affecting its financial outlook, including potential unexpected safety issues associated with its Enhanced Delivery Oligonucleotide (EDO) platform, which could hinder the development of its pipeline product PGN-EDODM1. The company also encounters regulatory uncertainty, as established pathways for approval of its conditions, particularly for DM1, are not fully defined, potentially extending the time frame for gaining necessary approvals. Additionally, external negative news related to similar technologies could adversely impact investor sentiment and stock performance, contributing to a bearish outlook for PepGen's shares.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.